HK2 and neoplasm: We therefore hypothesized that if HK2 endowed tumor cells with a proliferative advantage and apoptotic resistance in response to EBV-encoded LMP1, knocking down the expression of HK2 might decrease glycolysis and survival advantage in LMP1-overexpressing cells.